Health News

FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin

FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin Print this page THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Kanjinti (trastuzumab-anns) for all approved indications of the reference product, Herceptin® (trastuzumab): for the treatment of HER2-overexpressing adjuvant… Read More: FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin »

Digital innovation moving slowly in healthcare, study shows

A new study of healthcare innovation shows progress toward new approaches to care delivery could use a nudge. The report, entitled, “Trends for Scaling Innovation in Health Care,” was based on a survey of 29 health system executives from 28 unique health systems, and found that while many health systems and their affiliated health plans… Read More: Digital innovation moving slowly in healthcare, study shows »

Setting Goals to be More Active Slows Memory Decline in Older African Americans

Older African Americans with mild cognitive impairment (MCI) who got help setting goals to be more socially, physically, or cognitively active had slower memory decline than those who did not receive such help, concludes an NIA-funded study published Sept. 10 in JAMA Neurology. The results point to a possible way to reduce dementia risk in… Read More: Setting Goals to be More Active Slows Memory Decline in… »

Harvard study links red meat consumption with early death

People who increased their daily servings of red meat over an eight-year period were more likely to die during the subsequent eight years than those who did not increase their red meat consumption, according to a new study led by researchers from Harvard T.H. Chan School of Public Health. The study also found that decreasing… Read More: Harvard study links red meat consumption with early death »